- Home
- ROIV vs PCOR Comparison
ROIV vs PCOR Comparison
Compare ROIV & PCOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- PCOR
- Stock Information
- Founded
- ROIV 2014
- PCOR 2003
- Country
- ROIV United Kingdom
- PCOR United States
- Employees
- ROIV N/A
- PCOR N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- PCOR Computer Software: Prepackaged Software
- Sector
- ROIV Health Care
- PCOR Technology
- Exchange
- ROIV Nasdaq
- PCOR Nasdaq
- Market Cap
- ROIV 8.6B
- PCOR 10.2B
- IPO Year
- ROIV N/A
- PCOR 2021
- Fundamental
- Price
- ROIV $12.92
- PCOR $70.14
- Analyst Decision
- ROIV Strong Buy
- PCOR Buy
- Analyst Count
- ROIV 4
- PCOR 20
- Target Price
- ROIV $15.50
- PCOR $81.95
- AVG Volume (30 Days)
- ROIV 5.2M
- PCOR 1.5M
- Earning Date
- ROIV 08-11-2025
- PCOR 10-29-2025
- Dividend Yield
- ROIV N/A
- PCOR N/A
- EPS Growth
- ROIV N/A
- PCOR N/A
- EPS
- ROIV N/A
- PCOR N/A
- Revenue
- ROIV $23,233,000.00
- PCOR $1,232,484,000.00
- Revenue This Year
- ROIV N/A
- PCOR $15.31
- Revenue Next Year
- ROIV $281.14
- PCOR $12.73
- P/E Ratio
- ROIV N/A
- PCOR N/A
- Revenue Growth
- ROIV N/A
- PCOR 16.08
- 52 Week Low
- ROIV $8.73
- PCOR $52.78
- 52 Week High
- ROIV $13.08
- PCOR $88.92
- Technical
- Relative Strength Index (RSI)
- ROIV 73.31
- PCOR 57.10
- Support Level
- ROIV $11.85
- PCOR $67.13
- Resistance Level
- ROIV $13.08
- PCOR $70.49
- Average True Range (ATR)
- ROIV 0.31
- PCOR 1.91
- MACD
- ROIV 0.10
- PCOR 0.63
- Stochastic Oscillator
- ROIV 89.61
- PCOR 81.63
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About PCOR Procore Technologies Inc.
Procore Technologies Inc is a cloud-based construction management software company. It generates revenue through subscriptions for access to its software products. The company's products include Design Coordination, BIM, Field Productivity, Project Financials, Invoice Management, Portfolio Financials, Capital Planning, Accounting Integrations, and Analytics. The software products are hosted on its cloud-based SaaS construction management platform. Subscriptions are sold for a fixed fee and revenue is recognized ratably over the term of the subscription.